Nu Skin Enterprises Stock Performance
| NUS Stock | USD 7.13 0.09 1.25% |
Nu Skin has a performance score of 2 on a scale of 0 to 100. The company owns a Beta (Systematic Risk) of -0.3, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Nu Skin are expected to decrease at a much lower rate. During the bear market, Nu Skin is likely to outperform the market. Nu Skin Enterprises currently owns a risk of 4.08%. Please verify Nu Skin Enterprises potential upside, and the relationship between the jensen alpha and accumulation distribution , to decide if Nu Skin Enterprises will be following its current price history.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Nu Skin Enterprises are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Nu Skin may actually be approaching a critical reversion point that can send shares even higher in May 2025. ...more
Actual Historical Performance (%)
One Day Return (4.21) | Five Day Return (8.81) | Year To Date Return 4.12 | Ten Year Return (89.02) | All Time Return (76.24) |
Forward Dividend Yield 0.0337 | Payout Ratio | Forward Dividend Rate 0.24 | Dividend Date 2025-03-05 | Ex Dividend Date 2025-02-24 |
1 | Vanguard Group Inc Reduces Stake in Nu Skin Enterprises Inc | 01/31/2025 |
2 | Nu Skin signals 1.48B to 1.62B revenue range for 2025 with focus on operational efficiency | 02/14/2025 |
3 | Disposition of 1693 shares by Emma Battle of Nu Skin at 7.73 subject to Rule 16b-3 | 02/21/2025 |
4 | Is Nu Skin Enterprises Outperforming Other Consumer Staples Stocks This Year | 02/25/2025 |
5 | Zacks Investment Ideas feature highlights KT, Patria Investments, Nu Skin Enterprises and e.l.f. Beauty | 02/26/2025 |
6 | Acquisition by Edwina Woodbury of tradable shares of Nu Skin at 8.16 subject to Rule 16b-3 | 03/05/2025 |
7 | Six questioned by police over protest in NUS on Israel-Hamas war | 03/07/2025 |
8 | Insider Sell Emma Battle Sells 1,693 Shares of Nu Skin Enterpri - GuruFocus.com | 03/11/2025 |
9 | Are Consumer Staples Stocks Lagging Heineken This Year | 03/19/2025 |
10 | COTY Exits SKKN by Kim Partnership With Stake Sale to SKIMS | 03/24/2025 |
11 | Why Nu Skin Enterprises Is Surging in 2025 | 03/26/2025 |
12 | 3 Reasons NUS is Risky and 1 Stock to Buy Instead | 04/02/2025 |
| Begin Period Cash Flow | 256.1 M |
NUS |
Nu Skin Relative Risk vs. Return Landscape
If you would invest 691.00 in Nu Skin Enterprises on January 4, 2025 and sell it today you would earn a total of 22.00 from holding Nu Skin Enterprises or generate 3.18% return on investment over 90 days. Nu Skin Enterprises is generating 0.1301% of daily returns assuming volatility of 4.0802% on return distribution over 90 days investment horizon. In other words, 36% of stocks are less volatile than NUS, and above 98% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Nu Skin Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nu Skin's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Nu Skin Enterprises, and traders can use it to determine the average amount a Nu Skin's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0319
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | NUS | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.08 actual daily | 36 64% of assets are more volatile |
Expected Return
| 0.13 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Nu Skin is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nu Skin by adding it to a well-diversified portfolio.
Nu Skin Fundamentals Growth
NUS Stock prices reflect investors' perceptions of the future prospects and financial health of Nu Skin, and Nu Skin fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on NUS Stock performance.
| Return On Equity | -0.2 | ||||
| Return On Asset | 0.0342 | ||||
| Profit Margin | (0.08) % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 619.84 M | ||||
| Shares Outstanding | 49.72 M | ||||
| Price To Earning | 10.70 X | ||||
| Price To Book | 0.52 X | ||||
| Price To Sales | 0.20 X | ||||
| Revenue | 1.73 B | ||||
| Gross Profit | 1.22 B | ||||
| EBITDA | (151.59 M) | ||||
| Net Income | (146.59 M) | ||||
| Cash And Equivalents | 264.73 M | ||||
| Cash Per Share | 7.69 X | ||||
| Total Debt | 452.05 M | ||||
| Debt To Equity | 0.59 % | ||||
| Current Ratio | 2.30 X | ||||
| Book Value Per Share | 13.08 X | ||||
| Cash Flow From Operations | 111.74 M | ||||
| Earnings Per Share | (2.95) X | ||||
| Market Capitalization | 339.61 M | ||||
| Total Asset | 1.47 B | ||||
| Retained Earnings | 1.71 B | ||||
| Working Capital | 241.99 M | ||||
| Current Asset | 706.39 M | ||||
| Current Liabilities | 407.6 M | ||||
About Nu Skin Performance
Assessing Nu Skin's fundamental ratios provides investors with valuable insights into Nu Skin's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Nu Skin is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 126.20 | 140.38 | |
| Return On Tangible Assets | (0.11) | (0.11) | |
| Return On Capital Employed | (0.13) | (0.12) | |
| Return On Assets | (0.10) | (0.09) | |
| Return On Equity | (0.23) | (0.21) |
Things to note about Nu Skin Enterprises performance evaluation
Checking the ongoing alerts about Nu Skin for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Nu Skin Enterprises help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Nu Skin Enterprises had very high historical volatility over the last 90 days | |
| The company reported the last year's revenue of 1.73 B. Reported Net Loss for the year was (146.59 M) with profit before taxes, overhead, and interest of 1.22 B. | |
| Nu Skin Enterprises has a strong financial position based on the latest SEC filings | |
| Over 77.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: 3 Reasons NUS is Risky and 1 Stock to Buy Instead |
- Analyzing Nu Skin's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nu Skin's stock is overvalued or undervalued compared to its peers.
- Examining Nu Skin's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Nu Skin's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nu Skin's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Nu Skin's stock. These opinions can provide insight into Nu Skin's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for NUS Stock Analysis
When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.